Immucor (Norcross, Georgia), a provider of automated instrument-reagent systems to the blood transfusion industry, said it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital (Fort Worth, Texas) in a transaction valued at about $1.97 billion. News of the agreement sent Immucor shares up 30%. (Medical Device Daily)